BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 15855637)

  • 21. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis.
    De Langhe E; Cailotto F; De Vooght V; Aznar-Lopez C; Vanoirbeek JA; Luyten FP; Lories RJ
    Respir Res; 2015 Mar; 16(1):38. PubMed ID: 25849157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis.
    Borensztajn K; Bresser P; van der Loos C; Bot I; van den Blink B; den Bakker MA; Daalhuisen J; Groot AP; Peppelenbosch MP; von der Thüsen JH; Spek CA
    Am J Pathol; 2010 Dec; 177(6):2753-64. PubMed ID: 20971733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
    Lin C; Duitman J; Daalhuisen J; Ten Brink M; von der Thüsen J; van der Poll T; Borensztajn K; Spek CA
    Thorax; 2014 Feb; 69(2):152-60. PubMed ID: 24029744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.
    Cai Y; Kimura S
    PLoS One; 2015; 10(11):e0142497. PubMed ID: 26559674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein tyrosine phosphatase α mediates profibrotic signaling in lung fibroblasts through TGF-β responsiveness.
    Aschner Y; Khalifah AP; Briones N; Yamashita C; Dolgonos L; Young SK; Campbell MN; Riches DW; Redente EF; Janssen WJ; Henson PM; Sap J; Vacaresse N; Kapus A; McCulloch CA; Zemans RL; Downey GP
    Am J Pathol; 2014 May; 184(5):1489-502. PubMed ID: 24650563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficiency of Psgl-1 accelerates bleomycin (BLM)-induced lung fibrosis and inflammation in mice through activating PI3K/AKT.
    Han X; Wang SM
    Biochem Biophys Res Commun; 2017 Sep; 491(2):558-565. PubMed ID: 28263743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Inflammatory, Antioxidant, and Antifibrotic Effects of Gingival-Derived MSCs on Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Wang X; Zhao S; Lai J; Guan W; Gao Y
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
    Dong SH; Liu YW; Wei F; Tan HZ; Han ZD
    Biomed Pharmacother; 2017 May; 89():1297-1309. PubMed ID: 28320097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombospondin-1-deficient mice are not protected from bleomycin-induced pulmonary fibrosis.
    Ezzie ME; Piper MG; Montague C; Newland CA; Opalek JM; Baran C; Ali N; Brigstock D; Lawler J; Marsh CB
    Am J Respir Cell Mol Biol; 2011 Apr; 44(4):556-61. PubMed ID: 20581099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
    Russo RC; Guabiraba R; Garcia CC; Barcelos LS; Roffê E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice.
    Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A
    Am J Respir Cell Mol Biol; 2008 May; 38(5):566-71. PubMed ID: 18096870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cthrc1 lowers pulmonary collagen associated with bleomycin-induced fibrosis and protects lung function.
    Binks AP; Beyer M; Miller R; LeClair RJ
    Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28292882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.
    Lakos G; Takagawa S; Chen SJ; Ferreira AM; Han G; Masuda K; Wang XJ; DiPietro LA; Varga J
    Am J Pathol; 2004 Jul; 165(1):203-17. PubMed ID: 15215176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin-induced pulmonary fibrosis in mice.
    Gupte VV; Ramasamy SK; Reddy R; Lee J; Weinreb PH; Violette SM; Guenther A; Warburton D; Driscoll B; Minoo P; Bellusci S
    Am J Respir Crit Care Med; 2009 Sep; 180(5):424-36. PubMed ID: 19498056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia.
    Kseibati MO; Sharawy MH; Salem HA
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107011. PubMed ID: 33045575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
    Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
    Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulated immune cell recruitment orchestrated by c-MET impairs pulmonary inflammation and fibrosis.
    Barbosa-Matos C; Borges-Pereira C; Libório-Ramos S; Fernandes R; Oliveira M; Mendes-Frias A; Silvestre R; Osório NS; Bastos HN; Santos RF; Guimarães S; Morais A; Mazzone M; Carvalho A; Cunha C; Costa S
    Respir Res; 2024 Jun; 25(1):257. PubMed ID: 38909206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.
    Scotton CJ; Krupiczojc MA; Königshoff M; Mercer PF; Lee YC; Kaminski N; Morser J; Post JM; Maher TM; Nicholson AG; Moffatt JD; Laurent GJ; Derian CK; Eickelberg O; Chambers RC
    J Clin Invest; 2009 Sep; 119(9):2550-63. PubMed ID: 19652365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin.
    Chen ES; Greenlee BM; Wills-Karp M; Moller DR
    Am J Respir Cell Mol Biol; 2001 May; 24(5):545-55. PubMed ID: 11350823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.